Welcome to InterK

InterK Peptide Therapeutics is a preclinical biotechnology company developing immunoboosting synthetic peptides with potential use as adjuvants in vaccination strategies, promoting DNA repair following UV irradiation, maintaining immune tolerance during cancer immunotherapy AND as a therapeutic in endometriosis.

Preclinical development of peptide-based therapeutic candidates in Sydney Australia

Share this page